Douglas Lane & Associates LLC Lowers Stock Position in GE HealthCare Technologies Inc. $GEHC

Douglas Lane & Associates LLC trimmed its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 1.4% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 440,681 shares of the company’s stock after selling 6,427 shares during the quarter. Douglas Lane & Associates LLC owned about 0.10% of GE HealthCare Technologies worth $33,095,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Vanguard Group Inc. boosted its position in shares of GE HealthCare Technologies by 1.4% in the second quarter. Vanguard Group Inc. now owns 52,107,758 shares of the company’s stock worth $3,859,622,000 after purchasing an additional 703,903 shares during the period. Dodge & Cox lifted its stake in shares of GE HealthCare Technologies by 42.1% during the 2nd quarter. Dodge & Cox now owns 23,567,950 shares of the company’s stock valued at $1,745,678,000 after buying an additional 6,982,441 shares in the last quarter. State Street Corp boosted its holdings in GE HealthCare Technologies by 1.9% in the 2nd quarter. State Street Corp now owns 19,660,742 shares of the company’s stock worth $1,456,271,000 after buying an additional 372,755 shares during the period. Geode Capital Management LLC increased its stake in GE HealthCare Technologies by 2.0% in the 2nd quarter. Geode Capital Management LLC now owns 11,944,407 shares of the company’s stock worth $881,060,000 after buying an additional 231,302 shares in the last quarter. Finally, Norges Bank bought a new stake in GE HealthCare Technologies during the second quarter valued at about $468,120,000. Institutional investors own 82.06% of the company’s stock.

Analyst Ratings Changes

GEHC has been the subject of a number of recent analyst reports. Citigroup upped their price objective on GE HealthCare Technologies from $83.00 to $88.00 and gave the stock a “neutral” rating in a research note on Thursday, December 11th. Wall Street Zen downgraded GE HealthCare Technologies from a “buy” rating to a “hold” rating in a research note on Saturday, September 20th. Weiss Ratings reiterated a “hold (c+)” rating on shares of GE HealthCare Technologies in a research report on Monday, December 15th. Stifel Nicolaus set a $90.00 target price on shares of GE HealthCare Technologies in a report on Friday, November 21st. Finally, BTIG Research reaffirmed a “buy” rating and set a $87.00 target price on shares of GE HealthCare Technologies in a research note on Friday, November 21st. Six research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. Based on data from MarketBeat.com, GE HealthCare Technologies currently has an average rating of “Moderate Buy” and a consensus target price of $87.09.

GE HealthCare Technologies Stock Performance

NASDAQ:GEHC opened at $82.89 on Friday. The company has a market cap of $37.76 billion, a price-to-earnings ratio of 17.13, a PEG ratio of 3.46 and a beta of 1.10. GE HealthCare Technologies Inc. has a 1 year low of $57.65 and a 1 year high of $94.80. The stock’s 50 day simple moving average is $77.69 and its two-hundred day simple moving average is $75.42. The company has a debt-to-equity ratio of 0.83, a current ratio of 1.18 and a quick ratio of 0.95.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its earnings results on Wednesday, October 29th. The company reported $1.07 earnings per share for the quarter, beating analysts’ consensus estimates of $1.05 by $0.02. GE HealthCare Technologies had a net margin of 10.94% and a return on equity of 22.52%. The firm had revenue of $5.14 billion during the quarter, compared to analyst estimates of $5.07 billion. During the same period last year, the firm posted $1.14 earnings per share. GE HealthCare Technologies’s revenue for the quarter was up 5.8% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. As a group, equities analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 13th. Stockholders of record on Friday, January 9th will be issued a $0.035 dividend. The ex-dividend date is Friday, January 9th. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. GE HealthCare Technologies’s payout ratio is 2.89%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.